6:41am ET
Investing
5 Rock-Solid Passive Income Dividend Aristocrats That Are Reasonably Safe From Tariffs
These five Dividend Aristocrats have the least negligible impact from the tariffs and are ideal for passive income investors.
ABBV Coverage Page 11
8:47am ET
Investing
One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs
Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding ideas for investors worn out from tariff-related volatility.
8:51am ET
Investing
iShares’ High-Yield HDV ETF – 7 Picks Powering Its High Yields
If you want a way to combine steady income, stability, and diversification, an exchange-traded fund (ETF) can deliver all three. The iShares Core High ETF (NYSEARCA:HDV) is worth looking into since it…
12:12pm ET
Investing
4 Reasons Schwab’s High-Yield SCHD ETF Is the Safest Bet Today
Yesterday’s wild rally in the stock market where $5.5 trillion in value following President Trump hitting a 90-day pause on his tariffs, exemplifies the dramatic swings investors have experienced for the past…
10:11am ET
Investing
Vanguard’s High-Yield VYM ETF – 6 Stocks Driving Its Big Payouts
Investing isn’t easy, and given the current market volatility, retail investors are on edge, worrying about their portfolios. About 20% of the S&P 500 stocks hit a 52-week low before the tariff…
4:44pm ET
Investing
4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff Winners
Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
1:51pm ET
Investing
Here Is Why Yield Hungry Investors Should Buy Schwab’s SCHD Over The Safe Vanguard VIG
In the 2020s, there are plenty of yield-focused exchange traded funds (ETFs) to choose from, and they’re not all created equal. Two popular dividend funds in particular — the Schwab U.S. Dividend…
11:26am ET
Investing
Only Have $500? 3 No-Brainer Stocks to Buy Right Now
Forget the old adage “it takes money to make money.” In the stock market, even a measly $500 can kickstart a fortune. Time, not a fat wallet, is the real MVP here.…
3:01pm ET
Investing
Billionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 Stocks
If you work in the biotech industry, you might know the name Alex Denner. If not, his name probably doesn’t ring a bell. Denner is the CEO and CIO of Sarissa Capital…
8:45am ET
Investing
Johnson & Johnson Just Paid Investors: Here’s How Much They Got
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
10:32am ET
Investing
Market Correction Wake-Up Call? 4 Dependable High-Yield Dividend Kings to the Rescue
One solid idea for growth and income investors who want to stay invested but shift to a more balanced approach is to look at the incredible Dividend Kings.
8:45am ET
Investing
AbbVie Just Paid Investors: Here’s How Much They Received
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
11:18am ET
Investing
AbbVie (ABBV) Earnings Live: Why The Stock Is Up Big Today
Live Updates Deep Dive into ABBV's Earnings Call 11:53am ETRich DupreyLooking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq Set to Dominate Immunology Market 2025 revenue projection:…
7:45am ET
Investing
Merck Just Paid Investors: How Much Did They Receive?
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
10:15am ET
Investing
Johnson & Johnson Just Paid Investors: Here’s How Much They Received
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.